MIT Libraries weigh in on the dispute between EndNote and Zotero

This is one of those entries that falls into the category of “probably only useful to me/reminder:” “Thomson Reuters vs. George Mason University (or EndNote vs. Zotero): the Business End of Citation Management Software.” The short version is that EndNote (which is a citation software that costs money) is suing Zotero (which is free) claiming trademark infringement and the like.

I include this here because I think it would be worthwhile to introduce this stuff into the discussion in English 516 this coming winter, though this prompts two other thoughts for now. First, I really gotta get on the stick and figure out what I’m doing in that course in a couple of months. Second, perhaps I should make some use of these kinds of resources. I am more or less “old school” when it comes to this stuff, preferring instead to just keep track of stuff in MS Word files or Scrivener or something. What I don’t like particularly about EndNote or Zotero is that they aren’t portable. Perhaps more useful for me would be to revive my citeulike account, and since there is a “group” function with this site, maybe it’d be a good route to take in 516 for the research project. Or English 121 for that matter….

2 thoughts on “MIT Libraries weigh in on the dispute between EndNote and Zotero”

  1. Hi Steve,

    I came across your post and would like to suggest you have a look at Mendeley (, I’m one of the co-founders), which is cross-platform/portable citation and reference management:

    Mendeley Desktop is free academic software for managing and sharing research papers (for Win, Linux, Mac). Mendeley Web is a free research network which lets you access your papers online, discover research trends and connect to like-minded researchers.

    There’s also a “group” functionality where you can tag, annotate, and share citations with a selected group of people.

    Hope you like it – keep in mind it’s still beta :)


Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.

This site uses Akismet to reduce spam. Learn how your comment data is processed.